GEA
ABBV icon

Glen Eagle Advisors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.54M Sell
19,067
-211
-1% -$39.2K 0.54% 35
2025
Q1
$4.04M Buy
19,278
+171
+0.9% +$35.8K 0.67% 32
2024
Q4
$3.4M Buy
19,107
+830
+5% +$147K 0.56% 36
2024
Q3
$3.61M Buy
18,277
+470
+3% +$92.8K 0.61% 35
2024
Q2
$3.05M Buy
17,807
+716
+4% +$123K 0.56% 38
2024
Q1
$3.11M Sell
17,091
-455
-3% -$82.9K 0.59% 40
2023
Q4
$2.72M Sell
17,546
-165
-0.9% -$25.6K 0.57% 41
2023
Q3
$2.64M Buy
17,711
+440
+3% +$65.6K 0.61% 37
2023
Q2
$2.33M Buy
17,271
+762
+5% +$103K 0.54% 43
2023
Q1
$2.63M Buy
16,509
+568
+4% +$90.5K 0.66% 37
2022
Q4
$2.58M Sell
15,941
-38
-0.2% -$6.14K 0.7% 37
2022
Q3
$2.14M Buy
15,979
+168
+1% +$22.5K 0.62% 38
2022
Q2
$2.42M Buy
15,811
+204
+1% +$31.2K 0.66% 39
2022
Q1
$2.53M Buy
15,607
+295
+2% +$47.8K 0.66% 37
2021
Q4
$2.07M Sell
15,312
-245
-2% -$33.2K 0.54% 43
2021
Q3
$1.68M Buy
15,557
+1,959
+14% +$211K 0.49% 51
2021
Q2
$1.53M Buy
13,598
+479
+4% +$54K 0.48% 51
2021
Q1
$1.41M Buy
13,119
+974
+8% +$105K 0.49% 48
2020
Q4
$1.3M Sell
12,145
-94
-0.8% -$10.1K 0.51% 45
2020
Q3
$1.07M Buy
12,239
+1,104
+10% +$96.7K 0.48% 47
2020
Q2
$1.09M Buy
11,135
+3,281
+42% +$322K 0.56% 43
2020
Q1
$598K Buy
7,854
+3,763
+92% +$287K 0.42% 54
2019
Q4
$362K Buy
4,091
+352
+9% +$31.2K 0.19% 107
2019
Q3
$283K Sell
3,739
-131
-3% -$9.92K 0.19% 112
2019
Q2
$281K Buy
3,870
+353
+10% +$25.7K 0.19% 111
2019
Q1
$283K Buy
3,517
+356
+11% +$28.7K 0.21% 105
2018
Q4
$291K Buy
3,161
+30
+1% +$2.77K 0.25% 90
2018
Q3
$296K Sell
3,131
-170
-5% -$16.1K 0.21% 107
2018
Q2
$306K Buy
3,301
+241
+8% +$22.3K 0.24% 92
2018
Q1
$290K Buy
3,060
+386
+14% +$36.5K 0.24% 99
2017
Q4
$259K Sell
2,674
-174
-6% -$16.8K 0.22% 103
2017
Q3
$253K Sell
2,848
-24
-0.8% -$2.13K 0.24% 104
2017
Q2
$208K Buy
2,872
+2
+0.1% +$145 0.17% 122
2017
Q1
$187K Buy
2,870
+2
+0.1% +$130 0.16% 126
2016
Q4
$180K Buy
+2,868
New +$180K 0.16% 127